✦ LIBER ✦

P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy

✍ Scribed by Broxterman, H J; Sonneveld, P; van Putten, W J L; Lankelma, J; Eekman, C A; Ossenkoppele, G J; Pinedo, H M; Löwenberg, B; Schuurhuis, G J

Book ID: 110054573
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 131 KB
Volume: 14
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2401796

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term survival after induction thera

Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia

✍ M. Flasshove; P. Meusers; J. Schütte; R. Noppeney; D. W. Beelen; S. Sohrab; U. R 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 119 KB

Treatment of acute myeloid leukemia of a

Treatment of acute myeloid leukemia of adults with cytosine arabinoside in combination with 6-mercaptopurine

✍ John G. Buchanan; John R. D. Matthews; J. Graham Davison; Robert R. Grigor; Thom 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Comparison of toxicity and outcome in pa

Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicin

✍ G. Seipelt; W.-K. Hofmann; H. Martin; B. Wassmann; A. Boehme; O. G. Ottmann; D. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 205 KB

Salvage treatment for primary resistant

Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: A phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group

✍ T. De Witte; S. Suciu; D. Selleslag; B. Labar; K. Roozendaal; R. Zittoun; M. Rib 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 156 KB

A phase II trial of induction and consol

A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

✍ Bouabdallah, R; Lefrère, F; Rose, C; Chaïbi, P; Harousseau, J-L; Vernant, J-P; C 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

The prognostic significance of leukemic

The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia

✍ Zhijian Xiao; Hua Xue; Rui Li; Li Zhang; Minghua Yu; Yushu Hao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views